Koneksa’s 2022 Year in Review

Dec 24, 2022

Koneksa at the CNS Summit: Advancing Digital Biomarkers in Parkinson’s Disease Research

Dec 1, 2022

Digital Biomarker Collaborations Are Super-Charging Neuroscience

Nov 1, 2022

Koneksa Announces Clinical Pipeline of Validated Digital Biomarkers to Accelerate Life Sciences Research

Oct 25, 2022

Reverse Translation Experts Gather in Zürich: Conference Recap

Oct 6, 2022

How Are Digital Biomarkers Reshaping Parkinson’s Disease Research?

Sep 23, 2022

The Koneksa Women’s Network: Building Community That Scales

Aug 9, 2022

Koneksa Awarded a Grant from The Michael J. Fox Foundation to Evaluate Disease Progression Using Digital Measures in Parkinson’s Disease

Aug 8, 2022

Leveraging Digital Biomarkers to Transform CNS Clinical Research

Aug 4, 2022

What Do BYOD Trials Need to Succeed?

Aug 1, 2022

Koneksa Appoints Dr. Maria C. Freire to Board of Directors

Jul 19, 2022

Koneksa CMO Speaks at FDA Workshop

Jul 5, 2022

Koneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease

Jun 16, 2022

Aural Analytics and Koneksa Announce Partnership to Support Clinical Trials Using Speech Analytics

Jun 14, 2022

Focus on Biomarker vs. eCOA

May 25, 2022

Small But Mighty: ASCPT Convenes Discussion of Innovative Clinical Trial Designs in Small Patient Populations

May 19, 2022

How much do we know about adherence to biometric monitoring technologies (BioMeTs) in clinical trials?

May 11, 2022

From Laboratory Biomarkers to Digital Biomarkers: Koneksa Leadership Explain the Journey in ASCPT Webinar

Apr 28, 2022

Koneksa at FDA Public Meeting on Multi-Component Biomarkers with CMO John Wagner

Apr 12, 2022

Koneksa at ASCPT with Chief Scientific Officer Dr. Elena Izmailova

Mar 29, 2022

Koneksa at the 2022 SCOPE Conference with Director of Digital Biomarkers Andrew Pearlmutter

Mar 3, 2022

How New FDA Guidance Will Help Advance Digital Health Technologies

Feb 24, 2022

Announcing $45M Series C Financing and Appointment of John Wagner as Chief Medical Officer

Feb 7, 2022

Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform

Feb 7, 2022

Koneksa at the CNS Summit with Chief Scientific Officer Dr. Elena Izmailova

Dec 1, 2021

Koneksa Broadens Multi-Year CNS Research Collaboration with Sanofi Digital Clinical Trial Collaboration Expands to Multiple Sclerosis

Nov 3, 2021

A Koneksa Digest: Examining Apple Watch

Sep 16, 2021

Playbook Digest: FOCUS ON PULSE OXIMETRY

Jul 23, 2021

The Playbook Digest: Remote Monitoring & At-Home Pulse Oximetry

Jul 22, 2021

New Research Presented at the FNIH Biomarkers Consortium

Jun 17, 2021

Koneksa Supports DiMe’s New EVIDENCE Checklist for Evaluating Digital Measurement Products

Jun 16, 2021

New Research Presented at ATS on Remote Spirometry Compliance in Patients with Asthma

May 25, 2021

New Research Presented at the ISCTM 2021 Annual Meeting

Apr 14, 2021

The Playbook Digest: The New Digital Medicine Manual & Its Impact in Oncology

Apr 5, 2021

ATS Suggests Home Spirometry for Pulmonary Medicine Services During the Pandemic

Jan 8, 2021

BEYOND THE CLINIC: Remote Spirometry Data Collection in Respiratory Diseases

Jan 7, 2021

A New Look for Digital Biomarkers

Nov 25, 2020

Webinar Recap and Replay: Remote Spirometry Data Collection in Respiratory Diseases

Nov 18, 2020

Implementing Digital Endpoints in Neuroscience Clinical Trials

Nov 17, 2020

An Introduction to Actigraphy & Best Practices for Clinical Trials

Nov 17, 2020

Koneksa Completes $16M Series B Financing to Expand Digital Biomarker Platform

Sep 28, 2020

Webinar Recap and Replay: Actigraphy in Clinical Research

Jul 30, 2020